MFWM
Motley Fool Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2M | Buy |
475,949
+126,970
| +36% | +$6.98M | 1.58% | 14 |
|
|
2025
Q1 | $24.7M | Buy |
348,979
+1,251
| +0.4% | +$88.4K | 1.46% | 18 |
|
|
2024
Q4 | $22.7M | Sell |
347,728
-76,869
| -18% | -$5.02M | 1.17% | 21 |
|
|
2024
Q3 | $29.8M | Sell |
424,597
-21,106
| -5% | -$1.48M | 1.5% | 15 |
|
|
2024
Q2 | $36.7M | Sell |
445,703
-13,032
| -3% | -$1.07M | 1.87% | 13 |
|
|
2024
Q1 | $40.1M | Sell |
458,735
-11,554
| -2% | -$1.01M | 2.07% | 11 |
|
|
2023
Q4 | $45.4M | Sell |
470,289
-18,667
| -4% | -$1.8M | 2.38% | 10 |
|
|
2023
Q3 | $43.3M | Buy |
488,956
+159,421
| +48% | +$14.1M | 2.5% | 9 |
|
|
2023
Q2 | $28.6M | Sell |
329,535
-7,271
| -2% | -$631K | 1.68% | 16 |
|
|
2023
Q1 | $32.8M | Sell |
336,806
-1,836
| -0.5% | -$179K | 2.05% | 14 |
|
|
2022
Q4 | $35M | Sell |
338,642
-4,247
| -1% | -$439K | 2.43% | 8 |
|
|
2022
Q3 | $29.1M | Sell |
342,889
-6,100
| -2% | -$517K | 1.9% | 14 |
|
|
2022
Q2 | $28.9M | Sell |
348,989
-8,001
| -2% | -$663K | 1.82% | 16 |
|
|
2022
Q1 | $27.5M | Buy |
356,990
+128,822
| +56% | +$9.93M | 1.31% | 23 |
|
|
2021
Q4 | $20.2M | Sell |
228,168
-5,535
| -2% | -$489K | 0.88% | 38 |
|
|
2021
Q3 | $18.1M | Sell |
233,703
-6,807
| -3% | -$526K | 0.79% | 43 |
|
|
2021
Q2 | $20.1M | Sell |
240,510
-3,811
| -2% | -$318K | 0.84% | 41 |
|
|
2021
Q1 | $18.4M | Sell |
244,321
-2,560
| -1% | -$193K | 0.83% | 43 |
|
|
2020
Q4 | $21.6M | Buy |
246,881
+1,792
| +0.7% | +$157K | 0.96% | 37 |
|
|
2020
Q3 | $18.6M | Buy |
245,089
+1,528
| +0.6% | +$116K | 0.97% | 32 |
|
|
2020
Q2 | $30M | Sell |
243,561
-7,188
| -3% | -$887K | 1.71% | 12 |
|
|
2020
Q1 | $21.2M | Sell |
250,749
-12,511
| -5% | -$1.06M | 1.53% | 19 |
|
|
2019
Q4 | $22.3M | Buy |
+263,260
| New | +$22.3M | 1.34% | 21 |
|